Food And Drug Administration-Acorda Therapeutics-Multiple Sclerosis-Biogen Idec Inc

FDA warns about seizures with MS drug Ampyra

WASHINGTON (Reuters) - The U.S. Food And Drug Administration on Monday said people who take the multiple sclerosis drug Ampyra, from Biogen Idec Inc and Acorda Therapeutics Inc, have a higher risk of seizures when starting the treatment. The FDA also updated the label for Ampyra, which is approved to help MS patients walk, to warn about the need to check kidney function before people start taking it, and every year after that. (Reporting by Anna Yukhananov; Editing by Maureen Bavdek) read more..

source:http://yhoo.it/Osb8wp

Cost Body Backs Novartis-National Institute-Multiple Sclerosis-Pill Gilenya-Novartis Ag

Cost body backs Novartis MS pill in about-turn

LONDON (Reuters) - Novartis's multiple sclerosis pill Gilenya, one of its top new drug hopes, has been recommended for use in the state health service after a change of heart by the country's healthcare cost-effectiveness watchdog. Friday's verdict from the National Institute for Health and Clinical Excellence (NICE), whose opinions are also watched closely in other countries, is welcome news for a product that has run into problems recently. ... read more..

source:http://yhoo.it/yX9wqY